Connect with us

Business

First shipment of Moderna vaccine arrives in New Brunswick – CBC.ca

Published

 on


Another 1,200 New Brunswickers will be vaccinated against COVID-19 beginning next week after the first shipment of Moderna vaccine arrived in the province Wednesday afternoon.

Shawn Berry, a spokesperson with the Department of Health, said 2,400 doses were expected. Since half of the shipment is going to be reserved for the second dose to be administered after 28 days, only 1,200 New Brunswickers will be getting shots this time around.

Berry said the province is collaborating with partner agencies to administer the vaccine to long-term care residents in nursing homes and adult residential facilities around the province. 

He said the “vast majority” of vaccines will go to long-term care residents, including a long-term care facility within a First Nations community. He said the priority is for residents over the age of 85.

While New  Brunswick hasn’t been specific about when other “older” populations will be eligible to receive the vaccine, the National Advisory Committee on Immunization suggested that people over 70 be in the first wave of vaccinations. The committee recommended starting with people over 80 and then decreasing by five-year increments to 70 as supply becomes available.

“As availability of the vaccine increases and eligibility is expanded, information will be provided to indicate how individuals in other eligible groups can register to receive the vaccine,” Berry said by email. 

Public Health Agency of Canada guidelines for who should get vaccinated for COVID-19 first. (CBC News)

Berry said a small number of doses may go to those who work at long-term care facilities, or to health-care workers, but only if there’s enough to go around after the priority residents are vaccinated.

He said health officials are currently contacting facilities around the province to arrange vaccinations beginning next week. 

“As availability of the vaccine increases and eligibility is expanded, information will be provided to indicate how individuals in other eligible groups can register to receive the vaccine,” said Berry. 

The province’s first vaccination clinic was held in Miramichi on Dec. 19 and 20. A second clinic was held Dec. 23, 24 and 27 in Moncton. Both of those clinics used the Pfizer-BioNTech vaccine. 

So far, two COVID-19 vaccines have been approved for use in Canada. 

The Pfizer-BioNTech vaccine was approved by Health Canada on Dec. 9, and the first doses arrived in New Brunswick on Dec. 15. 

Moderna’s vaccine was approved on Dec. 23 “after a thorough, independent review of the evidence” on safety, efficacy and quality requirements, officials said in a release.

The two vaccines are among several that have been pre-ordered by the Canadian government.

A nurse prepares a dose of the Pfizer-BioNTech COVID-19 vaccine at a clinic at St. Michael’s Hospital, in Toronto. (Evan Mitsui/CBC)

Both require an initial dose and a followup one — Pfizer-BioNTech after 21 days and Moderna after 28. 

Pfizer-BioNTech has said its vaccine is 95 per cent effective at preventing COVID-19, while Moderna said its vaccine is more than 94 per cent effective. 

The province has said more doses of the Pfizer-BioNTech vaccine are on the way, with 3,900 scheduled to arrive next week, and “regular deliveries” starting the week of Jan. 11.

Let’s block ads! (Why?)



Source link

Continue Reading

Business

Pfizer vaccine delay means BC is prioritizing second doses | News – Daily Hive

Published

 on


BC’s top doctor says the province’s most vulnerable residents should all receive their COVID-19 vaccine by the end of March, despite Pfizer’s shipping delay.

The vaccine manufacturer is making upgrades to its European facility to increase the number of doses it can produce. But in the short term, countries receiving shipments from that facility will get fewer doses.

Such delays are to be expected in a large and global vaccine rollout, Dr. Bonnie Henry said at her Monday news conference.

“It’s a bit of a setback but is only a delay,” she said. “We are still on track to protect the most vulnerable by the end of March.”

Due to the delay, a higher proportion of vaccine doses the province has on hand will be going toward second doses and fewer will be used for first doses. BC is still confident second doses can be administered at the 35-day mark.

In the meantime, it’s important that people keep their distance, wear masks, wash their hands, and don’t participate in social gatherings, Henry said.

The most significant impact of Pfizer’s shipping delays will be felt in late January and early February.

During the week of January 25, Pfizer will only deliver one-quarter of Canada’s expected COVID-19 vaccine doses. In the first two weeks of February, the company will deliver half of the expected doses.

Let’s block ads! (Why?)



Source link

Continue Reading

Business

Ontario's first major COVID-19 vaccination site will pause after just 5 days due to supply shortage – CTV Toronto

Published

 on


TORONTO —
Toronto Fire Chief Matthew Pegg says a pilot COVID-19 vaccination clinic that just opened today at the Metro Toronto Convention Centre will have to pause vaccinations on Friday because of a shortage of vaccine supply in the province.

The proof-of-concept clinic opened Monday and is meant to help develop a blueprint for how shots should be administered in non-medical settings as soon as this spring. So far, COVID-19 vaccines have only been administered at long-term care homes and at 19 hospital sites across Ontario.

Pegg said last week the facility would be “scale-able” and capable of increasing output with little notice, with an initial target of 250 doses per day.

But at the city’s media briefing on Monday, he said the province has now asked the city to pause vaccinations at the new clinic by the end of Friday.  

“We were all disappointed to learn that the delivery of Pfizer vaccine to Canada is expected to be delayed as a result of manufacturing delays in Europe. As a result, we have now been advised by the province that we will only be able to operate this proof of concept clinic for an initial five days due to the lack of availability of COVID-19 vaccine,” Pegg said.

He said anyone with an appointment at the clinic from Jan. 23 on should expect that their appointment will be cancelled.

Peg said those who receive their first dose at the clinic this week will still be able to get their second dose within the proper timeframe.

The clinic will resume vaccinations once it gets word from the province that it may do so. In the meantime, Pegg said the city is continuing to plan for a quick rollout of the vaccine when more doses become available.

“We are continuing to explore all options to accelerate our ability to administer vaccines to Toronto residents once larger quantities of vaccine are available,” he said. “This will include planning for extended hours of clinic operations, expanded clinic capacity targets and implementing innovative delivery methods that meet the needs of our city, including mobile vaccine clinics, priority neighborhood response, hospital-led clinic operations and widespread public access via pharmacies and primary care physicians.”

The site had been expected to run for at least six weeks in order to gather data about how best to host vaccination drives in larger settings.

Ontario Premier Doug Ford and Tory toured the site at MTCC’s North Building just on Sunday.

While the clinic was meant to use the Moderna vaccine, the Pfizer delays mean that some of that supply will now be redistributed to other parts of the province.

Let’s block ads! (Why?)



Source link

Continue Reading

Business

Couche-Tard to pursue other deals after Carrefour failure – BNN

Published

 on


Executives at Alimentation Couche-Tard Inc. defended a failed bid for Carrefour SA and said they would still like to buy the French grocer some day, but will turn their focus to other potential deals.

The Canadian convenience store operator made a US$20 billion offer that was shot down by French Finance Minister Bruno Le Maire on Friday. The bid caught investors off guard because Couche-Tard does not operate supermarkets.

The shares tumbled nearly 11 per cent last week. On Monday, they were up 2.4 per cent to $38.90 as of 9:36 a.m. in Toronto.

In response to criticism of the deal, Couche-Tard executive chairman Alain Bouchard said previous large deals — including the 2003 acquisition of Circle K — also surprised the market, but they worked out.

“Over the last decades while growing our business we have made many bold moves, some of which were not always obvious to our stakeholders,” Bouchard said on a conference call with investors Monday.

“Was I hoping our bold approach to Carrefour would have turned out differently? Of course. Yet I’m tremendously proud that Couche-Tard had the financial strength and acumen to make such an offer.”

The companies announced the end of negotiations on Saturday, four days after Bloomberg first reported the talks, and said they’ll work instead on a looser alliance in areas including fuel purchasing and product distribution.

Couche-Tard executives gave few details on that alliance Monday, calling the talks exploratory. Chief Executive Officer Brian Hannasch said there is a “robust” set of other acquisitions to examine as it pursues a five-year goal of doubling profit by 2023.

Hannasch said the door is open to a future Carrefour merger if the political climate in France changes.

“I’m old enough to believe there’s no such thing as permanently,” he said. “We’d love to do the transaction, so if we got signals that the environment could change or would change from the French government or the key stakeholders, we’d love the opportunity to re-engage — under the right conditions and assuming we haven’t found another way to create more value for our shareholders.”

The Laval, Quebec-based company has been making headway on its growth plans even without a major acquisition in recent years. Analysts expect adjusted earnings per share to be 16 per cent higher for the fiscal year that ends in April, according to data compiled by Bloomberg. Even so, its valuation has dipped.

The chain has been improving its coffee and adding fresh food offerings, which come with higher margins. It’s digging into analytics to improve pricing and promotions, and planning to roll out electric vehicle charging stations in North America after learning from its experience in Norway.

Couche-Tard strengthened its foothold in Asia by buying about 370 stores in Hong Kong and Macau that previously were Circle K brand licensees. But a large takeover has remained elusive since it signed a US$4 billion purchase of Texas-based CST Brands Inc. in 2016.

In April, the company walked away from a US$5.6 billion proposal for gas station chain Caltex Australia Ltd. (now known as Ampol Ltd.), citing pandemic uncertainty. And it missed out on Marathon Petroleum Corp.’s Speedway gas stations, which were scooped up in August by Japan’s Seven & i Holdings Co., the world’s largest convenience store operator, for US$21 billion.

Balance Sheet

Couche-Tard executives have scoffed at the valuation of Speedway. Addressing shareholders at the company’s annual meeting in September, Bouchard cited it as an example of the company’s discipline around acquisitions.

The balance sheet leaves it in a good place to hunt for deals. The company had about US$5.5 billion in net debt at the end of its October quarter, according to data compiled by Bloomberg. It’s earned US$3.5 billion in operating profit in the last four quarters.

Chief Financial Officer Claude Tessier told analysts in November that the current debt ratio is at half of Couche-Tard’s comfort level.

Let’s block ads! (Why?)



Source link

Continue Reading

Trending